المؤلفون: Godby RC; Department of Medicine, Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA. godby.richard@mayo.edu., Smith CJ; Department of Medicine, Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN, USA.

المصدر: Journal of cancer education : the official journal of the American Association for Cancer Education [J Cancer Educ] 2024 May 22. Date of Electronic Publication: 2024 May 22.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Springer Country of Publication: England NLM ID: 8610343 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-0154 (Electronic) Linking ISSN: 08858195 NLM ISO Abbreviation: J Cancer Educ Subsets: MEDLINE

المؤلفون: Qualls DA; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Lambert N; Department of Medicine, Baylor College of Medicine, Houston, TX., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Merrill M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pullarkat P; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Godby RC; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wehmeyer GT; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA., Amoozgar B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Leslie L; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abramson JS; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nowakowski GS; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rutherford SC; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Kahl B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Okwali M; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Buege MJ; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Seshan V; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

المصدر: Blood [Blood] 2023 Dec 28; Vol. 142 (26), pp. 2327-2331.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Lymphoma, Large B-Cell, Diffuse*/drug therapy, Humans ; Lenalidomide/therapeutic use ; Treatment Outcome ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Godby RC; Mayo Clinic, Rochester, MN.

المصدر: JCO oncology practice [JCO Oncol Pract] 2023 Dec; Vol. 19 (12), pp. 1093-1096. Date of Electronic Publication: 2023 Oct 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Fellowships and Scholarships* , Hematology*/education, Humans ; Medical Oncology/education ; Education, Medical, Graduate ; Reference Standards

المؤلفون: May JE; Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA. jemay@uabmc.edu., Lauzon SD; Eli Lilly and Company, Indianapolis, IN, USA., Godby RC; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kanter J; Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA.

المصدر: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2022 Jul; Vol. 54 (1), pp. 193-196. Date of Electronic Publication: 2022 Apr 19.

نوع المنشور: Letter; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Kluwer Academic Publishers Country of Publication: Netherlands NLM ID: 9502018 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-742X (Electronic) Linking ISSN: 09295305 NLM ISO Abbreviation: J Thromb Thrombolysis Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell*/complications , Anemia, Sickle Cell*/diagnosis , Pulmonary Embolism*/diagnosis , Pulmonary Embolism*/etiology, Fibrin Fibrinogen Degradation Products ; Humans

المؤلفون: Magnusson T; Division of General Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Godby RC; Division of General Internal Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Bachiashvili K; Division of Hematology Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Jamy O; Division of Hematology Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: British journal of haematology [Br J Haematol] 2022 Feb; Vol. 196 (4), pp. e27-e29. Date of Electronic Publication: 2021 Oct 14.

نوع المنشور: Case Reports; Letter; Retracted Publication

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Dyskeratosis Congenita/*genetics, Adult ; Heterozygote ; Humans ; Male ; Mutation

المؤلفون: Godby RC; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Raju D; Cancer Treatment Centers of America, Boca Raton, Florida., Massicano F; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Williams LA; Department of Pathology, Division of Laboratory Medicine, Mayo Clinic, Phoenix, Arizona., Black B; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Dorn D; Cunningham Pathology, Tuscaloosa, Alabama, USA., Marques MB; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

المصدر: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Oct 01; Vol. 32 (7), pp. 528-530.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 9102551 Publication Model: Print Cited Medium: Internet ISSN: 1473-5733 (Electronic) Linking ISSN: 09575235 NLM ISO Abbreviation: Blood Coagul Fibrinolysis Subsets: MEDLINE

مواضيع طبية MeSH: Hemophilia A*/complications , Hemostatics*, Factor VIII ; Humans ; Obesity/complications

المؤلفون: Godby RC; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kornbrust A; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Noubouossie D; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Kanter J; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Ogunsile FJ; Department of Medicine, Division of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Lima JLO; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Singh N; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Marques MB; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Siniard RC; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. O168-O170. Date of Electronic Publication: 2021 Feb 12.

نوع المنشور: Letter

بيانات الدورية: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-553X (Electronic) Linking ISSN: 17515521 NLM ISO Abbreviation: Int J Lab Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia, Sickle Cell/*epidemiology , COVID-19/*epidemiology , Health Resources/*supply & distribution, Anemia, Sickle Cell/therapy ; Blood Transfusion ; COVID-19/virology ; Humans ; Pandemics ; United States

المؤلفون: Godby RC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: rgodby@uabmc.edu., Dai C; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Al-Obaidi M; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Giri S; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Young-Smith C; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Kenzik K; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., McDonald AM; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Paluri RK; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Gbolahan OB; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia S; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Williams GR; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

المصدر: Journal of geriatric oncology [J Geriatr Oncol] 2021 May; Vol. 12 (4), pp. 599-604. Date of Electronic Publication: 2020 Nov 04.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101534770 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-4076 (Electronic) Linking ISSN: 18794068 NLM ISO Abbreviation: J Geriatr Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Gastrointestinal Neoplasms*/complications , Gastrointestinal Neoplasms*/epidemiology , Quality of Life*, Activities of Daily Living ; Aged ; Depression/epidemiology ; Geriatric Assessment ; Humans

المؤلفون: Godby RC; Department of Medicine, Division of General Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, United States; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, United States. Electronic address: rgodby@uabmc.edu., Kraemer RR; Department of Medicine, Division of General Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., May J; Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States., Soni S; Teerthanker Mahaveer Medical College & Research Centre, Moradabad, UP, India., Reddy V; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, AL, United States., Thomas JV; Department of Radiology, Division of Diagnostic Radiology, University of Alabama at Birmingham, Birmingham, AL, United States., Mehta A; Department of Medicine, Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, United States.

المصدر: The American journal of the medical sciences [Am J Med Sci] 2021 Mar; Vol. 361 (3), pp. 388-393. Date of Electronic Publication: 2020 Oct 07.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0370506 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-2990 (Electronic) Linking ISSN: 00029629 NLM ISO Abbreviation: Am J Med Sci Subsets: MEDLINE

مواضيع طبية MeSH: Epstein-Barr Virus Infections/*diagnosis , Lymphohistiocytosis, Hemophagocytic/*diagnosis, Adult ; Chronic Disease ; Diagnosis, Differential ; Epstein-Barr Virus Infections/complications ; Epstein-Barr Virus Infections/virology ; Herpesvirus 4, Human/isolation & purification ; Humans ; India/ethnology ; Lymphohistiocytosis, Hemophagocytic/complications ; Lymphohistiocytosis, Hemophagocytic/genetics ; Male ; Perforin/analysis

SCR Disease Name: Hemophagocytic lymphohistiocytosis, familial, 2

المؤلفون: Godby RC; Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Johnson DB; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Williams GR; Division of Hematology/Oncology, Geriatrics, and Palliative Care, Institute of Cancer Outcomes and Survivorship, O'Neal Comprehensive Cancer Center at UAB, University of Alabama at Birmingham, 1600 7th Avenue South, Lowder 500, Birmingham, AL, 35233, USA. grwilliams@uabmc.edu.

المصدر: Current oncology reports [Curr Oncol Rep] 2019 May 07; Vol. 21 (7), pp. 56. Date of Electronic Publication: 2019 May 07.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Current Science Country of Publication: United States NLM ID: 100888967 Publication Model: Electronic Cited Medium: Internet ISSN: 1534-6269 (Electronic) Linking ISSN: 15233790 NLM ISO Abbreviation: Curr Oncol Rep Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Immunotherapy/*methods , Neoplasms/*drug therapy, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Humans ; Neoplasms/immunology ; Prognosis